Cite
Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease.
MLA
Yan Lin, et al. “Ruxolitinib Improves Hematopoietic Regeneration by Restoring Mesenchymal Stromal Cell Function in Acute Graft-versus-Host Disease.” Journal of Clinical Investigation, vol. 133, no. 15, Aug. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1172/JCI162201.
APA
Yan Lin, Quan Gu, Shihong Lu, Zengkai Pan, Zining Yang, Yapu Li, Shangda Yang, Yanling Lv, Zhaofeng Zheng, Guohuan Sun, Fanglin Gou, Chang Xu, Xiangnan Zhao, Fengjiao Wang, Chenchen Wang, Shiru Yuan, Xiaobao Xie, Yang Cao, Yue Liu, & Weiying Gu. (2023). Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease. Journal of Clinical Investigation, 133(15), 1–16. https://doi.org/10.1172/JCI162201
Chicago
Yan Lin, Quan Gu, Shihong Lu, Zengkai Pan, Zining Yang, Yapu Li, Shangda Yang, et al. 2023. “Ruxolitinib Improves Hematopoietic Regeneration by Restoring Mesenchymal Stromal Cell Function in Acute Graft-versus-Host Disease.” Journal of Clinical Investigation 133 (15): 1–16. doi:10.1172/JCI162201.